Stay updated on Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial

Sign up to get notified when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1; the page remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T13:45:40.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The study record page continues to display a 403 Forbidden error instead of study information.
    Difference
    0.2%
    Check dated 2026-10-03T14:13:07.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The study details page now displays a 403 Forbidden message, replacing the previous content and preventing access to the study record.
    Difference
    0.5%
    Check dated 2026-09-26T16:34:02.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error page instead of the study content. The new additions include the 403 header and basic HTML structure, indicating access is blocked, while the detailed study information previously on the page is no longer accessible.
    Difference
    20%
    Check dated 2026-09-19T19:18:18.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.5 to v3.6.6, indicating a new version of the study page was published. This appears to be a routine maintenance update to the page metadata rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-08-29T22:00:42.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page now shows a server error indicating the page is unavailable, and the detailed study content has been removed, leaving an inaccessible study record for NCT03631407.
    Difference
    19%
    Check dated 2026-08-08T17:25:47.000Z thumbnail image

Stay in the know with updates to Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.